India wants a bigger slice of the world’s pharmaceutical pie amid US-China tensions. But with its patchy record on safety and a looming deadline to raise quality controls, the programme Insight explores whether the country can step up. MUMBAI: Amid a rash of drug-related recalls and deaths, India’s pharmaceutical sector is racing to improve its quality and safety standards as it eyes a greater share of the global market. Just last year, toxic cough syrups from India were linked to the deaths of